Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,405.60
+53.40 (3.95%)
Jan 7, 2026, 12:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 141.46 billion as of January 6, 2026. Its market cap has decreased by -34.33% in one year.
Market Cap
141.46B
Enterprise Value
138.16B
Revenue
11.25B
Ranking
n/a
PE Ratio
43.78
Stock Price
1,405.60
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 141.46B, an increase of 43.42%. That is a compound annual growth rate of 16.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 139.95B | -0.59% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 922.62B |
| Mankind Pharma | 909.29B |
| Aurobindo Pharma | 705.91B |
| Fortis Healthcare | 690.60B |